Alessandra Ammazzalorso Selected Research

Nitric Oxide (Nitrogen Monoxide)

7/2020

Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Ammazzalorso Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2017
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 01/2016
4	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2016
4	Glioma (Gliomas) 07/2020 - 06/2017
3	Paraganglioma (Paragangliomas) 07/2022 - 01/2019
2	Infections 03/2023 - 01/2022
2	Inflammation (Inflammations) 02/2023 - 07/2020
2	Carcinogenesis 01/2023 - 05/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 11/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019 - 04/2019
1	Triple Negative Breast Neoplasms 05/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Obesity 07/2019
1	Hypertension (High Blood Pressure) 07/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Gallstones (Gallstone) 10/2018
1	Cholestasis 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 06/2017
1	Pathologic Processes 10/2016
1	Metabolic Diseases (Metabolic Disease) 05/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Cognitive Dysfunction 01/2016
1	Insulin Resistance 09/2015
1	Dyslipidemias (Dyslipidemia) 09/2015

Drug/Important Bio-Agent (IBA)

9	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2023 - 05/2016
4	Aromatase InhibitorsIBA 12/2021 - 01/2016
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2021 - 05/2018
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 11/2022 - 01/2016
2	Monoamine Oxidase (MAO)IBA 11/2022 - 10/2019
2	benzothiazoleIBA 07/2022 - 01/2019
2	LigandsIBA 01/2022 - 09/2015
2	Aromatase (CYP19)IBA 12/2021 - 11/2021
2	Fibric Acids (Fibrates)IBA 04/2019 - 09/2015
2	prolinamideIBA 01/2019 - 05/2018
2	Hormones (Hormone)IBA 06/2017 - 01/2016
1	NifurtimoxIBA 03/2023
1	Melarsoprol (Mel B)IBA 03/2023
1	Pentamidine (NebuPent)FDA LinkGeneric 03/2023
1	Suramin (Suramin Sodium)IBA 03/2023
1	Eflornithine (Ornidyl)FDA Link 03/2023
1	fexinidazoleIBA 03/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 11/2022
1	ResveratrolIBA 11/2022
1	Gemcitabine FDA Link 07/2022
1	Antineoplastic Agents (Antineoplastics)IBA 07/2022
1	BenzothiazolesIBA 07/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2022
1	Histone Deacetylase InhibitorsIBA 05/2022
1	Amino Acids FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	IndazolesIBA 12/2021
1	TriazolesIBA 12/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020
1	compound 17IBA 07/2020
1	GW 6471IBA 05/2020
1	AntioxidantsIBA 10/2019
1	acetamidineIBA 01/2019
1	CM544IBA 01/2019
1	Antifungal AgentsIBA 01/2019
1	SolutionsIBA 01/2019
1	AmidesIBA 01/2019
1	LipidsIBA 10/2018
1	SteroidsIBA 06/2017
1	StilbenesIBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	EnzymesIBA 10/2016
1	ZincIBA 10/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 09/2015
1	Therapeutic UsesIBA 09/2015

Therapy/Procedure

6	Therapeutics 05/2022 - 05/2018
2	Drug Therapy (Chemotherapy) 05/2022 - 01/2019
1	Radiotherapy 06/2017